Peter Boström - UTU Research Portal

Peter Boström

- Associate Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

11 of 12

Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates (2015)
- BMC Urology
Vaananen RM, Ochoa NT, Bostrom PJ, Taimen P, Pettersson K
Differential predictive roles of A- and B-type nuclear lamins in prostate cancer progression (2015)
- PLoS ONE
Saarinen I, Mirtti T, Seikkula H, Boström PJ, Taimen P
Diffusion-weighted imaging of prostate cancer: effect of b-value distribution on repeatability and cancer characterization (2015)
- Magnetic Resonance Imaging
Merisaari H, Toivonen J, Pesola M, Taimen P, Boström PJ, Pahikkala T, Aronen HJ, Jambor I
Erectile dysfunction cannot be used in primary screening of pre-diabetes (2015)
- Diabetes Research and Clinical Practice
Ettala OO, Korhonen PE, Syvanen KT, Kaipia AJ, Vahlberg TJ, Aarnio PT, Bostrom PJ
Eturauhasen sairaudet – Ennaltaehkäisy, tutkimukset ja hoito (2015) Boström Peter
Evaluation of different mathematical models for diffusion-weighted imaging of normal prostate and prostate cancer using high b-values: A repeatability study (2015)
- Magnetic Resonance in Medicine
Jambor Ivan, Merisaari Harri, Taimen Pekka, Boström Peter, Minn Heikki, Pesola Marko, Aronen Hannu Juhani
Genomic Predictors of Outcome in Prostate Cancer (2015)
- European Urology
Boström PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, Cooperberg MR
Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly Bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: Prospective randomised finnbladder-4 study (2015)
- European Urology
Järvinen R., Marttila T., Kaasinen E., Rintala E., Aaltomaa S., Kallio J., Liukkonen T., Puolakka V., Seppänen M., Tuhkanen K., Vaarala M., Viitanen J., Boström P.; FinnBladder Group
Mathematical models for diffusion-weighted imaging of prostate cancer using b values up to 2000 s/mm2: Correlation with Gleason score and repeatability of region of interest analysis (2015)
- Magnetic Resonance in Medicine
Jussi Toivonen, Harri Merisaari, Marko Pesola, Pekka Taimen, Peter J. Boström, Tapio Pahikkala, Hannu J. Aronen, Ivan Jambor
PSA ja eturauhassyövän verinäytediagnostiikka (2015)
- Duodecim
Seikkula H, Pettersson K, Boström PJ
Reply from authors re: Robert S. Svatek. Long-term outcomes of the FinnBladder-4 study. Eur Urol 2015;68:618-9: which type of maintenance matters? (2015)
- European Urology
Järvinen R, Kaasinen E, Marttila T, Rintala E, Boström P
Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer (2015)
- PLoS ONE
Boström MM, Irjala H, Mirtti T, Taimen P, Kauko T, Ålgars A, Jalkanen S, Boström PJ
Bulbourethral gland adenocarcinoma in a 25-year-old man without comorbidities – Radical resection of proximal urethrae with Mitrofanoff-type appendicovesicostomy (2014)
- Scandinavian Journal of Urology and Nephrology
Syvänen KT, Taimen P, Salminen A, Kuusisto K, Boström PJ
European Association of Urology (@Uroweb) – Recommendations on the Appropriate Use of Social Media (2014)
- European Urology
Morgan Rouprêt, Todd M. Morgan, Peter J. Bostrom, Matthew R. Cooperberg, Alexander Kutikov, Kate D. Linton, Joan Palou, Luis Martínez-Piñeiro, Henk van der Poel, Carl Wijburg, Andrew Winterbottom, Henry H. Woo, Manfred P. Wirth, James W.F. Catto
FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer (2014)
- Virchows Archiv
Yann Neuzillet, Bas W. G. van Rhijn, Nadia L. Prigoda, Bharati Bapat, Liyang Liu, Peter J. Bostrom, Neil E. Fleshner, Brenda L. Gallie, Alexandre R. Zlotta, Michael A. S. Jewett, Theo H. van der Kwast
Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept (2014)
- Progrès en Urologie
Neuzillet Y, Mertens L, Shariat S, Bostrom P, Mirtti T, Sagalowsky A, Ashfaq R, Broeks A, Van der Heijden M, Peters D, Curial C, De Jong J, Horenblas S, Hurst C, Tomlinson D, Knowles M, Bapat B, Jewett M, Zlotta A, Sanders J, Lotan Y, Van der Kwast T, Van Rhijn B
Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer (2014)
- European Medical Journal Urology
Syvänen K, Järveläinen H, Taimen P, Laato M, Boström PJ
Patient-derived tissue culture and xenograft models for studying prostate tumor responses to therapy (2014)
- European Journal of Cancer
Yu L, Kahkonen TE, Taimen P, Bostrom P, Tuomela J, Harkonen P
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy (2014)
- Urologic Oncology: Seminars and Original Investigations
Seikkula H, Syvänen K, Kurki S, Mirtti T, Taimen P, Laato M, Boström P
Kives- ja lisäkiveskasvaimet (2013) Urologia Laato M, Boström P